Kyivmedpreparat Logo

Kyivmedpreparat

A leading pharmaceutical producer of antibacterial, generic, and original medicines in various forms.

KMED | Ukrainian Stock Exchange

Overview

Corporate Details

ISIN(s):
UA4000106140
LEI:
Country:
Ukraine
Address:
139 Saksaganskogo Str., 01032 Kyiv
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kyivmedpreparat, a part of Arterium Corporation, is a pharmaceutical company that manufactures a wide range of medicinal products. The company is a leading national producer of antibacterial drugs and also offers a broad portfolio of generic and original medicines. Its products are manufactured in various forms, including powders for injection, tablets, capsules, soft medicinal products, and granules for oral solutions. The company focuses on developing patient-centric solutions, providing high-quality medicines, and supporting patients throughout their treatment.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Kyivmedpreparat filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kyivmedpreparat

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kyivmedpreparat via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GC CELL CORPORATION Logo
Biotech firm offering cell/gene therapy CDMO services and developing immune cell cancer therapies.
South Korea
144510
Gelteq Ltd Logo
Ingestible gel platform for enhanced oral delivery of drugs & nutrients for human & animal health.
United States of America
GELS
GemVax & KAEL Co.,Ltd. Logo
Makes contamination controls for semiconductors & develops Alzheimer's therapeutics.
South Korea
082270
Gencurix Inc. Logo
Develops molecular diagnostic tests for cancer detection, prognosis, and treatment selection.
South Korea
229000
GENEDRIVE PLC Logo
Develops rapid, point-of-care genetic tests for time-critical healthcare to personalize medicine.
United Kingdom
GDR
GENELUX Corp Logo
Developing oncolytic viral immunotherapies for difficult-to-treat cancers using a vaccinia virus.
United States of America
GNLX
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.
South Korea
109820
Generation Bio Co. Logo
Developing siRNA genetic medicines via targeted nanoparticles for autoimmune diseases.
United States of America
GBIO
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea
095700
Genfit S.A. Logo
Biopharma developing therapeutics and diagnostics for rare and life-threatening liver diseases.
United States of America
GNFT

Talk to a Data Expert

Have a question? We'll get back to you promptly.